Use of alefacept and etanercept in 3 patients whose psoriasis failed to respond to etanercept

James M Krell1

  • 1Total Skin and Beauty Dermatology Center, Birmingham, Alabama 35205, USA.

This article reports on the combined use of alefacept and etanercept in 3 patients whose psoriasis failed to respond adequately to etanercept. All patients maintained improvement for at least 8 weeks after completing 12 weeks of alefacept. No adverse events or infections were reported, and CD4+ T-cell counts remained above normal limits.